Literature DB >> 1898875

Validation of the Glasgow Meningococcal Septicemia Prognostic Score: a 10-year retrospective survey.

A P Thomson1, J A Sills, C A Hart.   

Abstract

OBJECTIVE: To derive performance characteristics for the Glasgow Meningococcal Septicemia Prognostic Score (GMSPS).
DESIGN: Retrospective case-note study.
SETTING: Two children's hospitals with Regional Intensive Care Unit. PATIENTS: One hundred twenty-three children with proven meningococcal septicemia (some with concurrent meningitis) from January 1, 1977 to December 31, 1986.
MEASUREMENTS AND MAIN RESULTS: All 14 children who died after arrival scored greater than or equal to 8 either on admission (n = 8) or afterward (n = 6). Of 109 survivors, five scored greater than or equal to 8 (two were postictal at the time of scoring). A GMSPS of greater than or equal to 10 at or after admission predicted death with sensitivity 100%, specificity 98%, and positive predictive value of 88%; for GMSPS of both greater than or equal to 8 or 9, the values were 100%, 95%, and 74%, respectively.
CONCLUSIONS: The GMSPS is a rapid clinical score that performs well in identifying children with poor prognosis who might benefit from early intensive care. It should be studied prospectively and compared with other scoring systems.

Entities:  

Mesh:

Year:  1991        PMID: 1898875     DOI: 10.1097/00003246-199101000-00010

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  21 in total

Review 1.  Infections diseases: meningococcal disease.

Authors:  C A Hart
Journal:  West J Med       Date:  2000-08

2.  What's up (or down and out) in US healthcare.

Authors:  H Baucher
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

3.  Improving promptness of antibiotic treatment in meningococcal disease.

Authors:  F A Riordan
Journal:  Emerg Med J       Date:  2001-05       Impact factor: 2.740

4.  Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo.

Authors:  O B Harrison; B D Robertson; S N Faust; M A Jepson; R D Goldin; M Levin; R S Heyderman
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

5.  Meningococcal bacterial DNA load at presentation correlates with disease severity.

Authors:  S J Hackett; M Guiver; J Marsh; J A Sills; A P J Thomson; E B Kaczmarski; C A Hart
Journal:  Arch Dis Child       Date:  2002-01       Impact factor: 3.791

Review 6.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

7.  Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash.

Authors:  E D Carrol; P Newland; F A I Riordan; A P J Thomson; N Curtis; C A Hart
Journal:  Arch Dis Child       Date:  2002-04       Impact factor: 3.791

8.  A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis.

Authors:  Enitan D Carrol; Alistair P J Thomson; Ashley P Jones; Graham Jeffers; C Anthony Hart
Journal:  Intensive Care Med       Date:  2005-08-27       Impact factor: 17.440

9.  Severity scores in meningococcal septicemia and severe infectious purpura with shock.

Authors:  F Leclerc; F Delepoulle; J F Diependaele; A Martinot; V Hue; V Flurin; C Fourier; M Chenaud
Journal:  Intensive Care Med       Date:  1995-03       Impact factor: 17.440

10.  Definition of a new score for severity of generalized Neisseria meningitidis infection.

Authors:  W Nürnberger; A Platonov; H Stannigel; V B Beloborodov; I Michelmann; R von Kries; S Burdach; U Göbel
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.